Fig 7 - uploaded by Miroslav Kolarik
Content may be subject to copyright.
Morphology of Sporocadus rosigena MV B1 on PDA a, MEA b and OA c after 14d at 24 °C. Obverse (first row) and reverse (middle row) are shown. d Conidia. Bar = 10 µm

Morphology of Sporocadus rosigena MV B1 on PDA a, MEA b and OA c after 14d at 24 °C. Obverse (first row) and reverse (middle row) are shown. d Conidia. Bar = 10 µm

Source publication
Article
Full-text available
This paper represents the results of screening a diversity of fungal endophytes associated with Vitis vinifera leaves and canes in the Czech Republic. The characterization of strains is based on morphological and phylogenetic analyses of ITS, EF1α and TUB2 sequence data. Our strain selection covers 16 species and seven orders belonging to Ascomycot...

Citations

... To date, thirteen species have been listed in the index fungorum (https://www.indexfungorum.org, accessed on 20 November 2023), all of them isolated as endophytes or epiphytes from different plant species [13][14][15][16]. Up to now, no specialized metabolites have been described from any of the members of this genus. ...
Article
Full-text available
Cancer is one of the leading causes of death worldwide, with breast cancer being the second cause of cancer-related mortality among women. Natural Products (NPs) are one of the main sources for drug discovery. During a screening campaign focused on the identification of extracts from Fundación MEDINA’s library inhibiting the proliferation of cancer cell lines, a significant bioactivity was observed in extracts from cultures of the fungus Angustimassarina populi CF-097565. Bioassay-guided fractionation of this extract led to the identification and isolation of herbarin (1), 1-hydroxydehydroherbarin (4) plus other three naphthoquinone derivatives of which 3 and 5 are new natural products and 2 is herein described from a natural source for the first time. Four of these compounds (1, 3, 4 and 5) confirmed a specific cytotoxic effect against the human breast cancer cell line MCF-7. To evaluate the therapeutic potential of the compounds isolated, their efficacy was validated in 3D cultures, a cancer model of higher functionality. Additionally, an in-depth study was carried out to test the effect of the compounds in terms of cell mortality, sphere disaggregation, shrinkage, and morphology. The cell profile of the compounds was also compared to that of known cytotoxic compounds with the aim to distinguish the drug mode of action (MoA). The profiles of 1, 3 and 4 showed more biosimilarity between them, different to 5, and even more different to other known cytotoxic agents, suggesting an alternative MoA responsible for their cytotoxicity in 3D cultures.